[1] [1] Lin Yongmei,Lu Ying. Advancement of medical treatment in benign hyperplasia of prostate [J]. Yunnan J. Tradi. Chin. Med. & Mat. Med.,2007,28(4):48-50

[2] [2] Mao Hui,Qi Shuyuan,Li Longying et al.. Drug for benign prostatic hyperplasia [J]. J. Jilin Med. Col.,2009,(2):113-115

[3] [3] Fu Yibo,Fen Zhengkai. Long follow-up of PVP in the clinical management of BPH:Long term efficacy comparable to TURP [J]. J. Clin. Urol.,2007,22(5):398-399

[4] [4] Cao Jingyi,Qi Jingguang,Yang Ning. The correlation between hemorrhage in TURP operation and the expression of MVD and VEGF in BPH [J]. Mod. Urol.,2009,14(1):29-31

[5] [5] A. J. Costello,W. G. Bowsher,D. M. Bolton et al.. Laser ablation of the prostate in patients with benign prostatic hypertrophy [J]. Br. J. Urol.,1992,69(6):603-608

[6] [6] R. S. Kuntzman,R. S. Malek,D. M. Barrett et al.. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers [J]. Urology,1997,49(5):703-708

[7] [7] R. S. Malek,D. M. Barrett,R. S. Kuntzman. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy:24 hours later [J]. Urology,1998,51(2):254-256

[8] [8] Hu Jiebin,Liu Weijun,Tan Xiaoqi et al.. Transurethral vaporization using greenlight laser for urethrostenosis or urethratresia [J]. Chin. J. Laser Med. & Surg.,2009,18(3):160-162

[9] [9] R. S. Malek,D. M. Barrett,R. S. Kuntzman. High-power potassium-titanyl-phosphate laser vaporization prostatectomy [J]. Mayo. Clin. Proc.,1998,73(8):798-801

[10] [10] S. L. Jacques. Laser-tissue interaction.Photochemical,photothermal,and photomechanical [J]. Surg. Clin N. Am.,1992,72(3):531-538

[11] [11] R. Ruszat,S. Wyler,T. Forster et al.. Complications of photoselective vaporization of the prostate [J]. Eur. Urol. Suppl.,2007,6:136

[12] [12] A. E. Te,T. R. Malloy,B. S. Stein et al.. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia:12 month results from the first United States multicenter prospective trial [J]. J. Urol.,2004,172(4 Pt 1):1404-1408

[13] [13] D. M. Bouchier-Hayes,P. Anderson,S. VanAppleton et al.. KTP laser versus transurethral resection:early results of a randomized trial [J]. J. Urol.,2006,20(8):580-585

[14] [14] A. E. Ehab,M. E. Mostafa. Holmium laser ablation (HoLAP) versus photoselective vaporization (PVP) of the prostate:a prospective randomized trial [J]. J. Urol.,2008,179:675-676

[15] [15] R. R. Gonzalez,S. D. Soni,B. Reddy et al.. Octogenarians with symptomatic benign prostatic hyperplasia (BPH) have similar outcomes after photoselective laser vaporization of the prostate (PVP) compared to a younger cohort despite increased comorbidities [J]. J. Urol. Suppl.,2008,179:631

[16] [16] Y. Kuwahara,H. Otsuki,I. Nagakubo et al.. Photoselective vaporization of the prostate in severe heart disease or dementia patients who are not candidates for TUR-P [J]. Nippon Hinyokika Gakkai Zasshi,2008,99(6):688-693

[17] [17] R. Ruszat,S. Wyler,T. Forster et al.. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation [J]. Eur. Urol.,2007,51(4):1031-1041